Polsinelli Represents Author Capital in Vanta Diagnostics Acquisition

Polsinelli recently represented Author Capital Partners (Author Capital) in connection with its platform Vanta Diagnostics’ acquisition of certain key laboratory testing and diagnostics assets.

Following the transaction, Vanta operates as a national lab testing and diagnostics platform providing a comprehensive range of diagnostic testing services across 45 states, including Wound-ID™, Urine-ID™, Derm-ID™ and a broad suite of additional molecular diagnostic tests.

More information about this acquisition can be found here.

The Polsinelli team involved in this transaction was led by Shareholder Lisa S. Katz and included Shareholders Sean A. Timmons, Kevin M. Coffey, Adam W. Smith, Mary Buckley Tobin, Kathleen Snow Sutton, John M. Robert, Michael Dolan, Edward J. Hannon, Jeffrey A. Goldman and Elizabeth T. Gross as well as Counsel E. Benton Keatley. Additional support was provided by Associates Salvatore J. Cali, David E. Bird, April Fortner and Mary Ann H. Quinn.